The present invention comprises compositions and methods for treating a tumor or neoplastic disease in a host, The methods employ conjugates comprising superantigen polypeptides or nucleic acids with other structures that preferentially bind to tumor cells and are capable of inducing apoptosis. Also provided are superantigen-glycolipid conjugates and vesicles that are loaded onto antigen presenting cells to activate both T cells and NKT cells. Cell-based vaccines comprise tumor cells engineered to express a superantigen along with glycolipids products which, when expressed, render the cells capable of eliciting an effective anti-tumor immune response in a mammal into which these cells are introduced. Included among these compositions are tumor cells, hybrid cells of tumor cells and accessory cells, preferably dendritic cells. Also provided are T cells and NKT cells activated by the above compositions that can be administered for adoptive immunotherapy.
本发明包括用于治疗宿主体内肿瘤或肿瘤性疾病的组合物和方法,这些方法采用了由超抗原
多肽或核酸与其他结构组成的共轭物,它们优先与肿瘤细胞结合,并能够诱导细胞凋亡。此外,还提供了超抗原-
糖脂共轭物和囊泡,将其装载到抗原呈递细胞上可激活 T 细胞和 NKT 细胞。以细胞为基础的疫苗由肿瘤细胞和
糖脂产品组成,前者能表达超抗原,后者能使细胞在引入这些细胞的哺乳动物体内引起有效的抗肿瘤免疫反应。这些成分包括肿瘤细胞、肿瘤细胞的杂交细胞和辅助细胞,最好是树突状细胞。此外,还提供了由上述组合物激活的 T 细胞和 NKT 细胞,这些细胞可用于采纳性免疫疗法。